146 related articles for article (PubMed ID: 36935789)
1. Combination of cataract surgery with intravitreal injection of dexamethasone intravitreal implant (Ozurdex) for uveitis-induced cataract.
Deng J; Sun WT; Ai H; Wang LP
Int J Ophthalmol; 2023; 16(3):361-366. PubMed ID: 36935789
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis.
Hasanreisoğlu M; Özdemir HB; Özkan K; Yüksel M; Aktaş Z; Atalay HT; Özdek Ş; Gürelik G
Turk J Ophthalmol; 2019 Oct; 49(5):250-257. PubMed ID: 31650791
[TBL] [Abstract][Full Text] [Related]
3. Utilizing dexamethasone intravitreal implant to control postoperative inflammation in refractory uveitis undergoing cataract surgery.
Li YT; Cui XX; Yang XT; Li B; Ren XJ; Li XR; Zhang XM
Int J Ophthalmol; 2021; 14(2):317-322. PubMed ID: 33614464
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
Larochelle MB; Smith J; Dacey MS
Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis.
Elhamaky TR
Indian J Ophthalmol; 2022 Jul; 70(7):2465-2470. PubMed ID: 35791135
[TBL] [Abstract][Full Text] [Related]
6. The Use of Ozurdex (Dexamethasone Intravitreal Implant) During Anterior Segment Surgery in Patients with Chronic Recurrent Uveitis.
Ragam AP; Kolomeyer AM; Nayak NV; Chu DS
J Ocul Pharmacol Ther; 2015; 31(6):344-9. PubMed ID: 26061893
[TBL] [Abstract][Full Text] [Related]
7. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative dexamethasone implant in uveitis patients with cataract undergoing phacoemulsification.
Gupta A; Ram J; Gupta A; Gupta V
Ocul Immunol Inflamm; 2013 Dec; 21(6):462-7. PubMed ID: 23941542
[TBL] [Abstract][Full Text] [Related]
9. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
Arcinue CA; Cerón OM; Foster CS
J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract.
Ren Y; Du S; Zheng D; Shi Y; Pan L; Yan H
BMC Ophthalmol; 2021 Jun; 21(1):245. PubMed ID: 34088282
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
12. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study.
Lam WC; Albiani DA; Yoganathan P; Chen JC; Kherani A; Maberley DA; Oliver A; Rabinovitch T; Sheidow TG; Tourville E; Wittenberg LA; Sigouin C; Baptiste DC
Clin Ophthalmol; 2015; 9():1255-68. PubMed ID: 26203215
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Intravitreal Dexamethasone Implant in Patients of Uveitis Undergoing Cataract Surgery.
Gupta G; Ram J; Gupta V; Singh R; Bansal R; Gupta PC; Gupta A
Ocul Immunol Inflamm; 2019; 27(8):1330-1338. PubMed ID: 30239239
[No Abstract] [Full Text] [Related]
14. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema.
Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R
Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343
[TBL] [Abstract][Full Text] [Related]
15. Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis.
Pichi F; Nucci P; Baynes K; Lowder CY; Srivastava SK
Int Ophthalmol; 2017 Feb; 37(1):221-228. PubMed ID: 27221263
[TBL] [Abstract][Full Text] [Related]
16. Outcome and Prognostic Factors of Phacoemulsification Cataract Surgery in Vogt-Koyanagi-Harada Uveitis.
Ji Y; Hu K; Li C; Li P; Kijlstra A; Eghrari AO; Lei B; Du L; Wan W; Yang P
Am J Ophthalmol; 2018 Dec; 196():121-128. PubMed ID: 30194930
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion.
Ryder SJ; Iannetta D; Bhaleeya SD; Kiss S
Clin Ophthalmol; 2015; 9():1109-16. PubMed ID: 26150689
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.
Sella R; Oray M; Friling R; Umar L; Tugal-Tutkun I; Kramer M
Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1777-82. PubMed ID: 26228441
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone Inserts in Noninfectious Uveitis: A Single-Center Experience.
Pohlmann D; Vom Brocke GA; Winterhalter S; Steurer T; Thees S; Pleyer U
Ophthalmology; 2018 Jul; 125(7):1088-1099. PubMed ID: 29459041
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis.
Bratton ML; He YG; Weakley DR
J AAPOS; 2014 Apr; 18(2):110-3. PubMed ID: 24698604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]